Today's biggest winners and losers in the stock market.

On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week:

- Moderna (MRNA) saw it shares soar to a record 177%, adding around $44 billion in value on Wednesday after it announced a personalized vaccine it developed with Merck (MRK) reduced the recurrence of melanoma in a large, late-stage trial. The breakthrough raises expectations for treating the deadliest form of skin cancer and shows the promise of the embattled mRNA technology.

- Crowdstrike (CRWD) shares fell after Axios reported the company chief technology officer is departing to start an AI-cyber fund. Current CTO Elia Zaitsev's new venture firm is reportedly targeting a $170 million fund. 

- Estée Lauder (EL) shares soared after the beauty conglomerate ended a run of three straight declines in annual revenue, reinforcing that turnaround efforts are paying off. The shares closed 16% higher in New York on Wednesday, the biggest daily gain since 2011. The advance pared the stock’s year-do-date decline to 6%.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners of the week:
- Moderna (MRNA) saw it shares soar to a record 177%, adding around $44 billion in value on Wednesday after it announced a personalized vaccine it developed with Merck (MRK) reduced the recurrence of melanoma in a large, late-stage trial. The breakthrough raises expectations for treating the deadliest form of skin cancer and shows the promise of the embattled mRNA technology.
- Crowdstrike (CRWD) shares fell after Axios reported the company chief technology officer is departing to start an AI-cyber fund. Current CTO Elia Zaitsev's new venture firm is reportedly targeting a $170 million fund.&nbsp;
- Est&eacute;e Lauder (EL) shares soared after the beauty conglomerate ended a run of three straight declines in annual revenue, reinforcing that turnaround efforts are paying off. The shares closed 16% higher in New York on Wednesday, the biggest daily gain since 2011. The advance pared the stock&rsquo;s year-do-date decline to 6%.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Weekly Roundup: Moderna Skyrockets, Crowdstrike Sinks, Estée Lauder Jumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/b33ee3d2-3d8a-472a-8433-b4ad0165b1a3/transcript